Article ID Journal Published Year Pages File Type
239025 Powder Technology 2007 12 Pages PDF
Abstract

Pharmaceutical grade lactose, the purest form of lactose commercially available, is usually contaminated with traces of lactose phosphate (LP), a component of whey, the by-product of cheese manufacturing. This work presents a study of the effects of LP addition on the kinetics of lactose crystal growth during isothermal and cooling seeded-batch crystallisations. The effect of LP is also compared with riboflavin, glucose-6-phosphate and potassium chloride, three other possible contaminants. Two techniques were used to define the growth rate constant (kg) of a power law function describing the crystallisation kinetics of ultra-pure lactose. At 30 °C, the value of kg decreased with increasing LP concentration, following a linear Langmuir adsorption isotherm up to 60 mg LP per kg dissolved lactose (ppm). The particle size distribution was affected for up to 8 h and a proportion of crystals had their shape modified by the presence of LP. Chemical analysis of the final lactose showed that LP was integrated within the crystals. Riboflavin produced changes comparable to LP for growth and size distribution while the other two compounds showed smaller effects. The results for isothermal crystallisations with LP addition were confirmed in the controlled cooling operation.

Graphical abstractThis study focused on the inhibitory effects of lactose phosphate, a contaminant of lactose, on the kinetics of crystal growth during isothermal and cooling seeded batch crystallisations. The action of lactose phosphate is also compared with three other possible contaminants. The particle size distribution was affected for up to 8 hours and a proportion of crystals had their shape modified.Figure optionsDownload full-size imageDownload as PowerPoint slide

Related Topics
Physical Sciences and Engineering Chemical Engineering Chemical Engineering (General)
Authors
, , , , ,